Literature DB >> 1868246

Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.

R Storb, J E Sanders, M Pepe, C Anasetti, F R Appelbaum, C D Buckner, H J Deeg, K Doney, J Hansen, P Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1868246

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Stem cell transplantation for aplastic anemia.

Authors:  George E Georges; Rainer Storb
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

Review 3.  Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.

Authors:  Reuven Or; Memet Aker; Michael Yechiel Shapira; Igor Resnick; Menachem Bitan; Simcha Samuel; Shimon Slavin
Journal:  Springer Semin Immunopathol       Date:  2004-09-30

4.  Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation.

Authors:  Sook Kyung Yum; Hye-Yoon Choi; Jae Wook Lee; Pil-Sang Jang; Nack-Gyun Chung; Dae-Chul Jeong; Bin Cho; Hack-Ki Kim
Journal:  Korean J Pediatr       Date:  2013-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.